Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
09/21/2011 | EP1945630B1 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
09/21/2011 | EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
09/21/2011 | CN102197035A Novel crystalline form and processes for its preparation |
09/21/2011 | CN102197034A Novel polymorphs of sunitinib and processes for their preparation |
09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof |
09/21/2011 | CN102196809A Agent for treatment of diabetic nephropathy |
09/21/2011 | CN102190653A Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device |
09/21/2011 | CN102190652A Preparation method of losartan metabolite EXP-3174 |
09/21/2011 | CN102190628A Preparation method of 5-fluoro-6-ethyl-4-hydroxypyrimidine intermediate and Voriconazole |
09/21/2011 | CN102190627A 9,10-phenanthroimidazole derivatives and use thereof as electroluminescent materials |
09/21/2011 | CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs |
09/21/2011 | CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole |
09/21/2011 | CN101538236B Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
09/21/2011 | CN101343250B Thrombopoietin mimetics |
09/20/2011 | US8022221 Aurora kinase modulators and method of use |
09/20/2011 | US8022210 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma |
09/20/2011 | US8022209 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
09/20/2011 | US8022206 Furo[3,2-C]pyridines |
09/20/2011 | US8022111 Piperazino sensitisers |
09/20/2011 | US8022097 Adamantane-dipyrromethane derivatives, method of preparation and applications in anion sensing |
09/20/2011 | US8022096 Pyrrolidine derivatives |
09/20/2011 | US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
09/20/2011 | US8022073 Substituted pyridazine compounds and fungicidal uses thereof |
09/20/2011 | US8022071 Nitrogenous heterocyclic compounds |
09/20/2011 | US8022062 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
09/20/2011 | US8022061 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |
09/20/2011 | CA2645856C Pyrazoles as 11-beta-hsd-1 |
09/20/2011 | CA2583737C Compounds and compositions as protein kinase inhibitors |
09/20/2011 | CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
09/20/2011 | CA2505033C Non-nucleoside reverse transcriptase inhibitors |
09/20/2011 | CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
09/20/2011 | CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
09/15/2011 | WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
09/15/2011 | WO2011112428A2 Arylvinylazacycloalkane compounds for constipation |
09/15/2011 | WO2011112191A1 Compounds for the treatment of hepatitis c |
09/15/2011 | WO2011111930A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
09/15/2011 | WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
09/15/2011 | WO2011111077A1 1, 2, 4-triazole derivatives and their anti mycobacterial activity |
09/15/2011 | WO2011110852A1 Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
09/15/2011 | WO2011110198A1 A process for making voriconazole |
09/15/2011 | US20110224434 Prodrugs of Heteroaryl Compounds |
09/15/2011 | US20110224432 Heteroaryl compounds and uses thereof |
09/15/2011 | US20110224334 Near-infrared-ray absorbing material containing cyanine compound, and cyanine compound |
09/15/2011 | US20110224273 Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors |
09/15/2011 | US20110224271 process for the preparation of olmesartan medoxomil |
09/15/2011 | US20110224259 Novel inhibitors |
09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
09/15/2011 | US20110224254 Novel inhibitors |
09/15/2011 | US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists |
09/15/2011 | US20110224229 Novel Crystalline Form |
09/15/2011 | US20110224219 Melanocortin receptor agonists |
09/15/2011 | US20110224211 Anti-Viral Compounds, Compositions, And Methods Of Use |
09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
09/15/2011 | US20110224189 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
09/15/2011 | US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents |
09/15/2011 | US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal |
09/15/2011 | CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
09/15/2011 | CA2792157A1 Arylvinylazacycloalkane compounds for constipation |
09/15/2011 | CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
09/14/2011 | EP2364974A1 N-(3-Phenylamino-quinoxalin-2-yl)-benzenesulfonamide derivatives as phosphatidylinositol 3-kinase inhibitors |
09/14/2011 | EP2364964A1 Novel anthracene derivative and organic electronic device using the same |
09/14/2011 | EP2364312A2 Preparation of crystalline palonosetron hydrochloride |
09/14/2011 | EP2364310A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
09/14/2011 | EP2364309A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
09/14/2011 | EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
09/14/2011 | EP2364307A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
09/14/2011 | EP2364302A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes |
09/14/2011 | EP2364296A1 Pyrrolidines |
09/14/2011 | EP2364295A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
09/14/2011 | EP2364185A1 Disubstituted phthalazine hedgehog pathway antagonists |
09/14/2011 | EP2231636B1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
09/14/2011 | EP2049501B1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
09/14/2011 | EP1911755B1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
09/14/2011 | EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
09/14/2011 | EP1471915B1 2,4-pyrimidinediamine compounds and their uses |
09/14/2011 | EP1446401B1 C5-modified indazolylpyrrolotriazines |
09/14/2011 | EP1346982B1 Vla-4 inhibitors |
09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
09/14/2011 | CN102186841A 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity |
09/14/2011 | CN102186840A Piperidine compounds, pharmaceutical composition comprising the same and its use |
09/14/2011 | CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
09/14/2011 | CN102186838A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
09/14/2011 | CN102186818A 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
09/14/2011 | CN102186816A Pesticidal (hetero) arylpyrrolidines |
09/14/2011 | CN102186809A Insecticidal 4-phenyl-1h-pyrazoles |
09/14/2011 | CN102186477A Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
09/14/2011 | CN102186475A Novel inhibitors |
09/14/2011 | CN102181171A Iso-indigo derivative and applications of the iso-indigo derivative |
09/14/2011 | CN102180867A Synthesis method of N-{2-[4-(2-pyrimidyl)-1-piperazine}adamantine-1-formide |
09/14/2011 | CN101786997B Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |